Showing results (11-20 of 576) with videos related to
Sort By:
Pageof 58
Neurologia (Barcelona, Spain)|June 23, 1999
[Pramipexol: a new dopaminergic agonist for the treatment of Parkinson disease]F Grandas, M L GalianoClinical Neuropharmacology|February 1, 1989
Motor response following repeated apomorphine administration is reduced in Parkinson's diseaseF Grandas, J A ObesoRevista De Neurologia|August 1, 1997
[Physiopathology of the dyskinesias induced by L-dopa]F Grandas, N López-ArizteguiJournal of Neurology|February 1, 2000
Risk factors for levodopa-induced dyskinesias in Parkinson's diseaseF Grandas, M L Galiano, C TaberneroMovement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
Clinical and CT scan findings in a case of cyanide intoxicationF Grandas, J Artieda, J A ObesoJournal of Neurology|June 9, 1998
Quality of life in patients with Parkinson's disease who transfer from standard levodopa to Sinemet CR: the STAR Study. The STAR Multicenter Study GroupF Grandas, P Martínez-Martín, G LinazasoroJournal of Neural Transmission (Vienna, Austria : 1996)|January 15, 2009
Risk of valvular heart disease associated with the use of dopamine agonists in Parkinson's disease: a systematic reviewMalcolm Steiger, W Jost, F Grandas, et al.Neurologia (Barcelona, Spain)|July 1, 1989
[Pharmacologic, surgical and infiltration of botulin toxin treatment in blepharospasm]F Grandas, J Elston, N Quinn, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1988
Blepharospasm: a review of 264 patientsF Grandas, J Elston, N Quinn, et al.Neurologia (Barcelona, Spain)|March 24, 2000
[Intracranial hypertension as the first clinical manifestation of gliomatosis cerebri]J A Cruz-Velarde, L Muñoz, R Rodrigálvarez, et al.Pageof 58